{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:25:09Z","timestamp":1788521109830,"version":"build-2803163510"},"reference-count":97,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T00:00:00Z","timestamp":1266537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec><jats:label\/><jats:p>Eur J Clin Invest 2010; 40 (4): 350\u2013359<\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Neurologic disorders are among the most common and important clinical manifestations associated with the antiphospholipid syndrome (APS). It is characterized by diverse neurological manifestations. These include stroke, transient ischaemic attack, Sneddon\u2019s syndrome, convulsions\/epilepsy, dementia, cognitive deficits, headaches\/migraine, chorea, multiple sclerosis\u2010like, transverse myelitis, ocular symptoms and Guillain\u2013Barr\u00e9 syndrome.<\/jats:p><jats:p><jats:bold>Material and methods\u2002<\/jats:bold> We review the latest data about neurologic disorders and APS.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> In patients under 45 years of age, 20% of strokes are potentially associated with APS. Our study group recently reported a correlation between primary APS and peripheral neuropathy. Only one study investigated the occurrence of peripheral neuropathy in patients diagnosed with PAPS through electrophysiological study and showed alterations in 35% of patients. The mechanism of nervous system involvement in APS is considered to be primarily thrombotic. However, other mechanisms have been described, such as antiphospholipid antibodies that bind to the neural tissue, deregulating their functions and having an immediate pathogenic effect.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> This review summarizes the latest data regarding the clinical aspects, radiological and therapeutic of major neurologic manifestations associated with antiphospholipid antibodies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2362.2010.02263.x","type":"journal-article","created":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T13:14:07Z","timestamp":1266585247000},"page":"350-359","source":"Crossref","is-referenced-by-count":96,"title":["Neurological manifestations of antiphospholipid syndrome"],"prefix":"10.1111","volume":"40","author":[{"given":"Carlos E. M.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joz\u00e9lio F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0409"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309106832"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra002974"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6399.1088"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91113-3"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1984.tb00856.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.44.4.281"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.46.8.605"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2006.05.010"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200001000-00006"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.2.114"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.79.928.81"},{"key":"e_1_2_8_14_2","first-page":"1344","article-title":"Features associated with epilepsy in the antiphospholipid syndrome","volume":"31","author":"Shoenfeld Y","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh408"},{"key":"e_1_2_8_16_2","article-title":"Multiple mononeuropathy secondary to thrombosis of the vasa nervorum in primary antiphospholipid syndrome: the first reported case","author":"Rodrigues CEM","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-001-0032-3"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2007.10.009"},{"key":"e_1_2_8_19_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0038-1656365","article-title":"Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity \u2013 studies in a thrombosis model","volume":"68","author":"Oosting JD","year":"1992","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118276"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400322"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu503oa"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu504oa"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.6.707"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb05733.x"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu500oa"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00422-6"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu409oa"},{"key":"e_1_2_8_29_2","first-page":"1675","article-title":"Antiphospholipid syndrome: an overview","volume":"168","author":"Hanly JG","year":"2003","journal-title":"CMAJ"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.17.2227"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120300680199015"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000085567"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198911000-00004"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994935"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90335-5"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2003.10.001"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.1.91"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.5.576"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000117575.48205.2D"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000031927.25510.D1"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309106917"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1082271"},{"key":"e_1_2_8_43_2","first-page":"47","article-title":"Anti\u2010phospholipid syndrome: clinical spectrum and therapeutical\/prophylactic strategies in the pediatric population","volume":"126","author":"Rigante D","year":"2008","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.6.1283"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.5.798"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb03755.x"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.79.935.550"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:25:1:61"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199907000-00001"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720070091"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-003-0399-8"},{"key":"e_1_2_8_52_2","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus\u2010like disease: good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D\u2019Cruz DP","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_8_53_2","first-page":"467","article-title":"Acute transverse myelitis in systemic lupus erythematosus: clinical presentation, treatment, and outcome","volume":"25","author":"Mok CC","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_8_54_2","first-page":"34","article-title":"Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies","volume":"17","author":"Lavelle C","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203306lu2272rr"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.13.2.189"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370418"},{"key":"e_1_2_8_58_2","first-page":"71","article-title":"Observation on anti\u2010brain antibody in serum of 110 epileptics","volume":"103","author":"Xie XK","year":"1990","journal-title":"Chin Med J"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(00)00180-7"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.46"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.01024.x"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2005.04.001"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2005.03.005"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg080"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120399678847524"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973766"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(96)00152-X"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(00)00025-0"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.681"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1433"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1987.0702093.x"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198911000-00003"},{"key":"e_1_2_8_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005990070023"},{"key":"e_1_2_8_76_2","article-title":"The antiphospholipid syndrome as a neurological disease","author":"Arnson Y","journal-title":"Semin Arthritis Rheum"},{"key":"e_1_2_8_77_2","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna G","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2004.05.002"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.11.005"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00884-9"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.4.517"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.81"},{"key":"e_1_2_8_83_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.5.647"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.040352"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-007-0004-3"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199912003-00013"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.3109\/08916939309010644"},{"key":"e_1_2_8_88_2","first-page":"107","article-title":"Catastrophic secondary antiphospholipid syndrome with peripheral nervous system involvement: a case report","volume":"58","author":"Erten N","year":"2004","journal-title":"Acta Med Okayama"},{"key":"e_1_2_8_89_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1082273"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/110.2.533"},{"key":"e_1_2_8_91_2","first-page":"140","article-title":"Multiple mononeuropathy due to vasculitis associated with anticardiolipin antibodies: a case report","volume":"44","author":"Jeruc J","year":"2006","journal-title":"Folia Neuropathol"},{"key":"e_1_2_8_92_2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1160\/TH06-03-0132","article-title":"Revision of the Sapporo criteria for the antiphospholipid syndrome \u2013 coming to grips with evidence and Thomas Bayes?","volume":"95","author":"Lackner JK","year":"2006","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_93_2","article-title":"Peripheral neuropathy in patients with primary antiphospholipid (Hughes\u2019) syndrome","author":"Santos MSF","journal-title":"Lupus"},{"key":"e_1_2_8_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.11.017"},{"key":"e_1_2_8_95_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504133321504"},{"key":"e_1_2_8_96_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035241"},{"key":"e_1_2_8_97_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-4-303"},{"key":"e_1_2_8_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm052"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2010.02263.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2010.02263.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:21:29Z","timestamp":1698780089000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2010.02263.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1365-2362.2010.02263.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02263.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,17]]}}}